These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20576233)

  • 21. Intravenous immunoglobulin-associated acute renal failure: case series and literature review.
    Itkin YM; Trujillo TC
    Pharmacotherapy; 2005 Jun; 25(6):886-92. PubMed ID: 15927908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravenous immunoglobulins in the treatment of polymyositis and dermatomyositis].
    Cherin P
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S48-50. PubMed ID: 10896990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute renal failure after intravenous use of immunoglobulin to treat myocarditis].
    Pordeus V; Tostes A; Mesquita CT; Mady C; Mesquita ET
    Arq Bras Cardiol; 2005 Feb; 84(2):167-9. PubMed ID: 15761642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute renal failure following intravenous immunoglobulin therapy in a HIV-infected patient.
    Metallidis S; Papaioannou M; Bokolas G; Kollaras P; Gogou V; Nikolaidis P
    Clin Nephrol; 2009 Feb; 71(2):196-7. PubMed ID: 19203515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin].
    Wojtecka A; Kade G; Bilbin-Bukowska A; Niemczyk S
    Pol Merkur Lekarski; 2012 Mar; 32(189):173-5. PubMed ID: 22568183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acute kidney failure following intravenous administration of high doses of immunoglobulins].
    Cabre P; Smadja D; Odry L; Donikian JC; Vernant JC
    Presse Med; 1994 Jan; 23(3):142. PubMed ID: 8177854
    [No Abstract]   [Full Text] [Related]  

  • 27. Important drug information: immune globulin intravenous (human).
    Epstein JS; Gaines A; Kapit R; Pierce R; Potter R; Varricchio F
    Int J Trauma Nurs; 1999; 5(4):139-40. PubMed ID: 10661146
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute renal insufficiency and cerebral infarction during high-dose intravenous immunoglobulin therapy].
    Chatot-Henry C; Smadja D; Mehdaoui H; Fournerie P; Drault JN; Brébion A; Sobesky G
    Rev Med Interne; 1998 Dec; 19(12):914-6. PubMed ID: 9887459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of early treatment with intravenous immunoglobulins in severe forms of dermatomyositis].
    Escriche D; de la Cruz J; Moreno MJ; Romero J
    Med Clin (Barc); 1995 Jan; 104(2):79. PubMed ID: 7869785
    [No Abstract]   [Full Text] [Related]  

  • 32. Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy.
    Chacko B; John GT; Balakrishnan N; Kirubakaran MG; Jacob CK
    Ren Fail; 2006; 28(2):193-5. PubMed ID: 16538981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intravenously-administered immunoglobulins as first-choice agent in juvenile dermatomyositis].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1979-82. PubMed ID: 8413708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose intravenous IgG treatment and acute renal failure.
    Veber B; Mohammedi I; Gachot B; Bédos JP; Wolff M
    Intensive Care Med; 1995 Mar; 21(3):288-9. PubMed ID: 7790625
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Levesque H; Reumont G; Ducrotte P; Cailleux N; Hatron PY; Devulder B; Courtois H
    J Rheumatol; 1999 Dec; 26(12):2706-9. PubMed ID: 10606390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophilia.
    McColl MD; Omran A; Walker ID; Lowe GD
    Haemophilia; 1999 Mar; 5(2):124-6. PubMed ID: 10215961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin for treatment of gastro-intestinal haemorrhage in dermatomyositis.
    Marie I; Levesque H; Cailleux N; Courtois H; Guédon C
    Ann Rheum Dis; 2001 Jul; 60(7):723-4. PubMed ID: 11436864
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute renal failure after intravenous immunoglobulin therapy.
    Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI
    J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Human immunoglobulins, adverse drug reaction, prevention].
    Grenouillet-Delacrea M; Longy-Boursier M
    Rev Med Interne; 2008 Jun; 29 Spec No 2():24-8. PubMed ID: 18927984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulin therapy.
    Stein LD; Roifman CM
    Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.